Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study Clark, V., Strange, C., Strnad, P., Sanchez, A., Kwo, P., Pereira, V., Van Hoek, B., Barjaktarevic, I., Corsico, A., Pons, M., Goldklang, M., Gray, M., Kuhn, B., Vargas, H., Vierling, J. M., Vuppalanchi, R., Brantly, M., Kappe, N., Chang, T., Schluep, T., Yi, M., Hamilton, J., San Martin, J., Loomba, R. ELSEVIER. 2023: S90-S91
View details for Web of Science ID 001037135100135